167 related articles for article (PubMed ID: 18954432)
1. The epidemiology of Varicella Zoster Virus infection in Italy.
Gabutti G; Rota MC; Guido M; De Donno A; Bella A; Ciofi degli Atti ML; Crovari P;
BMC Public Health; 2008 Oct; 8():372. PubMed ID: 18954432
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
[TBL] [Abstract][Full Text] [Related]
4. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
5. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
[TBL] [Abstract][Full Text] [Related]
6. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
Chang CK; Tan HF; Tseng HF; Lin CC
Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster virus transmission dynamics in Vojvodina, Serbia.
Medić S; Katsilieris M; Lozanov-Crvenković Z; Siettos CI; Petrović V; Milošević V; Brkić S; Andrews N; Ubavić M; Anastassopoulou C
PLoS One; 2018; 13(3):e0193838. PubMed ID: 29505590
[TBL] [Abstract][Full Text] [Related]
8. Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland.
Koskiniemi M; Lappalainen M; Schmid DS; Rubtcova E; Loparev VN
Clin Vaccine Immunol; 2007 Sep; 14(9):1057-61. PubMed ID: 17626161
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.
Balbi O; Baldi S; Rizza S; Pietroiusti A; Perrone S; Coppeta L
Hum Vaccin Immunother; 2021 Feb; 17(2):372-376. PubMed ID: 32643520
[TBL] [Abstract][Full Text] [Related]
10. The epidemiological situation of chickenpox in the Silesian voivodeship in the years 2011-2015 in view of data of the situation in Poland.
Cieślik-Tarkota R; Lorenc Z; Albertyńska M; Rozwadowska B; Jasik KP; Mendera-Bożek U
Przegl Epidemiol; 2016; 70(4):555-562. PubMed ID: 28214346
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
[TBL] [Abstract][Full Text] [Related]
13. The seroepidemiology of varicella in Italy.
Gabutti G; Penna C; Rossi M; Salmaso S; Rota MC; Bella A; Crovari P;
Epidemiol Infect; 2001 Jun; 126(3):433-40. PubMed ID: 11467800
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
16. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Sauerbrei A; Wutzler P
J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
[TBL] [Abstract][Full Text] [Related]
17. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
18. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
[TBL] [Abstract][Full Text] [Related]
19. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of varicella-zoster in Pakistan.
Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
